carbamylhydrazine has been researched along with Diseases, Metabolic in 1 studies
carbamylhydrazine: RN given refers to parent cpd
Excerpt | Relevance | Reference |
---|---|---|
"Owing to the parallelism between the in vitro insulin mimicry and the in vivo improvement of glucose handling elicited by benzylamine in rodents, the SSAO/VAP-1 substrates, with stronger effects on human adipocytes than benzylamine, show promising applications for the treatment of insulin resistance." | 3.76 | SSAO substrates exhibiting insulin-like effects in adipocytes as a promising treatment option for metabolic disorders. ( Attané, C; Balogh, B; Brenachot, X; Carpéné, C; Dunkel, P; Földi, A; Iffiú-Soltesz, Z; Mátyus, P; Mercader, J; Valet, P, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mercader, J | 1 |
Iffiú-Soltesz, Z | 1 |
Brenachot, X | 1 |
Földi, A | 1 |
Dunkel, P | 1 |
Balogh, B | 1 |
Attané, C | 1 |
Valet, P | 1 |
Mátyus, P | 1 |
Carpéné, C | 1 |
1 other study available for carbamylhydrazine and Diseases, Metabolic
Article | Year |
---|---|
SSAO substrates exhibiting insulin-like effects in adipocytes as a promising treatment option for metabolic disorders.
Topics: 3T3 Cells; Adipocytes; Adipokines; Amine Oxidase (Copper-Containing); Animals; Apelin; Benzylamines; | 2010 |